BfArM

The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) was established in 1995 as an independent federal higher authority. Operating within the purview of the Federal Ministry of Health, BfArM plays a critical role in the German government's health sector. Its primary mandate involves the rigorous regulation, oversight, and authorization of drugs and medical devices, ensuring public safety, product efficacy, and market integrity. This foundational work underpins national health standards.

With a significant operational footprint, BfArM manages its extensive activities across 2 distinct locations, including its central headquarters situated in Bonn, Germany. The organization is powered by a dedicated workforce of between 1,000 and 5,000 professionals committed to its complex regulatory mission. Generating an annual revenue of $228.5M, BfArM represents a substantial and vital entity within the public sector's administrative and scientific landscape. Meet BfArM's team to gain insight into the specialized expertise and commitment of the professionals who ensure stringent regulatory compliance and uphold public health standards.

As a pivotal governmental body, BfArM's comprehensive responsibilities encompass market surveillance, detailed risk assessment, and the crucial authorization processes for pharmaceuticals and advanced medical products. Its diligent work is indispensable for maintaining the highest standards in healthcare delivery and effectively protecting consumers from potential risks. The institute's strategic direction and precise operational execution are vital for advancing public health initiatives across Germany and contributing to the broader European Union health framework, as suggested by its #germany, #eu, and #europe hashtags.